↓ Skip to main content

Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme

Overview of attention for article published in BMC Cancer, December 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
157 Dimensions

Readers on

mendeley
135 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
Published in
BMC Cancer, December 2009
DOI 10.1186/1471-2407-9-444
Pubmed ID
Authors

Joost JC Verhoeff, Olaf van Tellingen, An Claes, Lukas JA Stalpers, Myra E van Linde, Dirk J Richel, William PJ Leenders, Wouter R van Furth

Abstract

The relevance of angiogenesis inhibition in the treatment of glioblastoma multiforme (GBM) should be considered in the unique context of malignant brain tumours. Although patients benefit greatly from reduced cerebral oedema and intracranial pressure, this important clinical improvement on its own may not be considered as an anti-tumour effect.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 5 4%
Brazil 1 <1%
Germany 1 <1%
Denmark 1 <1%
United Kingdom 1 <1%
Unknown 126 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 28 21%
Student > Ph. D. Student 25 19%
Student > Bachelor 13 10%
Professor > Associate Professor 12 9%
Student > Master 11 8%
Other 29 21%
Unknown 17 13%
Readers by discipline Count As %
Medicine and Dentistry 41 30%
Agricultural and Biological Sciences 26 19%
Engineering 11 8%
Biochemistry, Genetics and Molecular Biology 10 7%
Chemistry 5 4%
Other 17 13%
Unknown 25 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2010.
All research outputs
#3,707,488
of 22,653,392 outputs
Outputs from BMC Cancer
#873
of 8,237 outputs
Outputs of similar age
#21,244
of 163,413 outputs
Outputs of similar age from BMC Cancer
#4
of 25 outputs
Altmetric has tracked 22,653,392 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,237 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,413 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.